Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05815199 · ClinicalTrials.gov registry record · NA
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
A NA study of Cigarette Smoking, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05815199: Recruiting NA study of Cigarette Smoking, sponsored by NYU Langone Health.
NCT05815199 is a NA study of Cigarette Smoking that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 60 participants, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05815199, a NA study of Cigarette Smoking, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this open-label, randomized controlled trial study, participants who smoke combustible cigarettes (CC) and are diagnosed with Serious Mental Illness (SMI) will be randomized in two arms to receive harm-reduction counseling and Ecological Momentary Intervention text messaging (EMI) along with either e-cigarettes (EC) or nicotine replacement therapy (NRT) such as patch and lozenges to compare the efficacy in CC smoking reduction.
Primary Outcome
Measured via self-report (daily diary about smoking behavior) and verified by exhaled carbon-monoxide (eCO) level (\< 6 ppm).
Conditions Studied
Interventions
- OTHER E-cigarette (EC)
- OTHER Nicotine Replacement Therapy (NRT)
- BEHAVIORAL Harm-Reduction Counseling
- BEHAVIORAL Ecological Momentary Intervention (EMI) Text Messaging
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-11-13 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05815199 shows while recruiting
NCT05815199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Cigarette Smoking appearing as the primary indexed condition, and to 4 interventions - of which E-cigarette (EC) is the first listed.
NCT05815199 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05815199 about?
NCT05815199 is a clinical study titled "E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness". In this open-label, randomized controlled trial study, participants who smoke combustible cigarettes (CC) and are diagnosed with Serious Mental Illness (SMI) will be randomized in two arms to receive harm-reduction counseling and Ecological Momentary Intervention text messaging (EMI) along with eith...
What is the current status of trial NCT05815199?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-11-13. Estimated completion is 2026-03.
What conditions does trial NCT05815199 study?
This clinical trial studies the following conditions: Cigarette Smoking.
What interventions are being tested in trial NCT05815199?
The interventions under investigation include: E-cigarette (EC) (OTHER), Nicotine Replacement Therapy (NRT) (OTHER), Harm-Reduction Counseling (BEHAVIORAL), Ecological Momentary Intervention (EMI) Text Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT05815199?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05815199 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05815199's enrollment target sits among peer trials
60 30th of 45 higher than 16 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI